Amin JB, Salussolia CL, Chan K, Regan MC, Dai J, Zhou HX, Furukawa H, Bowen ME, Wollmuth LP. (2017) Divergent roles of a peripheral transmembrane segment in AMPA and NMDA receptors. J Gen Physiol. 2017 May 15. pii: jgp.201711762. doi: 10.1085/jgp.201711762. [Epub ahead of print]

Romero-Hernandez A, Furukawa H*. (2017) Novel mode of antagonist binding in NMDA receptors revealed by the crystal structure of the GluN1-GluN2A ligand-binding domain complexed to NVP-AAM077. Mol Pharmacol. 2017 May 3. pii: mol.116.107912. doi: 10.1124/mol.116.107912. [Epub ahead of print]

Romero-Hernandez A, Simorowski N, Karakas E, Furukawa H* (2016) Molecular Basis for Subtype Specificity and High-Affinity Zinc Inhibition in the GluN1-GluN2A NMDA Receptor Amino-Terminal Domain. Neuron. 2016 Dec 21;92(6):1324-1336. doi: 10.1016/j.neuron.2016.11.006.

Regan MC, Furukawa H* (2016) Deeper Insights into the Allosteric Modulation of Ionotropic Glutamate Receptors. Neuron. 2016 Sep 21;91(6):1187-9. doi: 10.1016/j.neuron.2016.09.013.

Malinauskas T, Furukawa H* (2016) Production of Heteromeric Transmembrane Receptors with Defined Subunit Stoichiometry. Structure. 2016 May 3;24(5):653-5. doi: 10.1016/j.str.2016.04.004.

Tajima N, Karakas E, Grant T, Simorowski N, Diaz-Avalos R, Grigorieff N*, Furukawa H* (2016) Activation of NMDA receptors and the mechanism of inhibition by ifenprodil. Nature. 2016 May 2;534(7605):63-8. doi: 10.1038/nature17679.

Regan MC, Romero-Hernandez A, Furukawa H* (2015) A structural biology perspective on NMDA receptor pharmacology and function. Curr Opin Struct Biol. 2015 Aug 14;33:68-75.

Karakas E, Regan MC, and Furukawa H* (2015).Emerging structural insights into the function of ionotropic glutamate receptors. Trends Biochem Sci. 2015 Jun;40(6):328-37.

Khatri A, Burger PB, Swanger SA, Hansen KB, Zimmerman S, Karakas E, Liotta DC, Furukawa H, Snyder JP, Traynelis SF. (2014). Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator. Mol Pharmacol. 86(5):548-60.

Karakas E, Furukawa H*. (2014) Crystal structure of a heterotetrameric NMDA receptor ion channel. Science, 344(6187): 992-997.

Jespersen A, Tajima N, Fernandez-Cuervo G, Garnier-Amblard E, Furukawa H* (2014). Structural insights into competitive antagonism in NMDA receptors. Neuron, 81(2):366-378.

Salussolia CL, Gan Q, Kazi R, Singh P, Allopenna J, Furukawa H, Wollmuth LP., (2013). A eukaryotic specific transmembrane segment is required for tetramerization in AMPA receptors. J Neurosci. 33(23): 9840-5.

Hansen KB, Tajima N, Risgaard R, Perszyk RE, Jørgensen L, Vance KM, Ogden KK, Clausen RP, Furukawa H*, Traynelis SF*. (2013). Structural determinants of agonist efficacy at the glutamate binding site of N-methyl-D-aspartate receptors. Mol Pharmacol. 84(1): 114-27.

Burger PB, Yuan H, Karakas E, Geballe M, Furukawa H, Liotta DC, Snyder JP, Traynelis SF., (2012). Mapping the Binding of GluN2B-Selective N-Methyl-D-aspartate Receptor Negative Allosteric Modulators. Mol Pharmacol, 82(2):344-359

Furukawa H*, (2012). Structure and function of glutamate receptor amino terminal domains. J. Physiol, 590(Pt 1): 63-72.

Karakas E, Simorowski N, and Furukawa H*, (2011). Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors. Nature, 475(7355): 249-253.

Vance K, Simorowski N, Traynelis S, Furukawa H*, (2011). Ligand-specific deactivation time course of GluN1/GluN2D NMDA receptors. Nature Commun, 2: 294.

Hansen K, Furukawa H, Traynelis, S, (2010). Control of assembly and function of glutamate receptors by the amino-terminal domain. Mol Pharmacol, 78: 535-549.

Karakas E, Simorowski N, Furukawa H*, (2009). Structure of the zinc-bound amino-terminal domain of the NMDA receptor NR2B subunit. EMBO J, 28(24): 3910-3920.

Jin R, Singh SK, Gu S, Furukawa H, Sobolevsky AI, Zhou J, Jin Y, Gouaux E, (2009). Crystal structure and association behaviour of the GluR2 amino-terminal domain. EMBO J, 28(12):1812-1823.

Jasti J, Furukawa H, Gonzales E, Gouaux E, (2007). Structure of acid-sensing ion channel 1 at 1.9 Å resolution and low pH. Nature, 449(7160): 316-323.

Vásquez V, Cortes DM, Furukawa H, Perozo E, (2007). An optimized purification and reconstitution method for the MscS channel: strategies for spectroscopical analysis. Biochemistry, 46(23): 6766-6773.

Takahashi H, Shin Y, Cho SJ, Zago WM, Nakamura T, Gu Z, Ma Y, Furukawa H, Liddington R, Zhang D, Tong G, Chen HS, Lipton SA (2007). Hypoxia enhances S-Nitrosylation-Mediated NMDA receptor inhibition via a thiol oxygen sensor motif. Neuron, 53(1): 53-64.

Furukawa H, Singh SK, Mancusso R, Gouaux E, (2005). Subunit arrangement and function in NMDA receptors. Nature, 438(7065): 185-192.

Inanobe A, Furukawa H, Gouaux E, (2005). Mechanism of partial agonist action at the NR1 subunit of NMDA receptors. Neuron, 47(1): 71-84.

Furukawa H, Gouaux E., (2003). Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core. EMBO J, 22(12): 2873-2885.

Furukawa H, Hamada T, Hayashi MK, Haga T, Muto Y, Hirota H, Yokoyama S, Nagasawa K, Ishiguro M, (2002). Conformation of ligands bound to the muscarinic acetylcholine receptor. Mol Pharmacol, 62(4): 778-787.

Furukawa H, Haga T, (2000). Expression of Functional M2 Muscarinic Acetylcholine Receptor in Escherichia coli. J Biochem, 127(1): 151-161.